Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia

被引:3
作者
Bubonja-Sonje, Marina [1 ,2 ]
Peruc, Dolores [1 ,3 ]
Abram, Maja [1 ,2 ]
Mohar-Vitezi, Bojana [1 ,2 ]
机构
[1] Univ Rijeka, Dept Microbiol & Parasitol, Fac Med, Brace Branchetta 20, Rijeka 51000, Croatia
[2] Clin Hosp Ctr Rijeka, Dept Clin Microbiol, Kresimirova 42, Rijeka 51000, Croatia
[3] Teaching Inst Publ Hlth Primorsko Goranska Cty, Dept Clin Microbiol, Kresimirova 52a, Rijeka, Croatia
关键词
anti-HBc; HBsAg mutants; HBV DNA; hepatitis B virus; occult HBV infection; MUTATIONS; HBC;
D O I
10.1016/j.aohep.2023.101156
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction and Objectives: Occult hepatitis B virus (HBV) infection (OBI) is characterised by low levels of hepatitis B virus (HBV) DNA in the blood/liver of patients with negative hepatitis B surface antigen (HBsAg). This study aimed to determine the OBI prevalence and virological characteristics (viral genotypes and HBsAg mutants) in patients with an "anti-HBc only" serological profile. Materials and Methods: A total of 24 900 serum samples were routinely screened for hepatitis B markers over a five-year period. All anti-HBc-positive/HBsAg-negative/anti-HBs-negative sera were selected and analysed for the presence of HBV DNA. Mutational analyses of the HBs gene and polymerase gene sequences were performed. Results: 1749 (7.02%) sera were anti-HBc positive, and 113 (0.45%) sera had an "anti-HBc only" serological profile (HBsAg/anti-HBs negative). HBV DNA was detected in 12/113 (10.61%) "anti-HBc only" positive sera, representing 0.048% of all routinely tested samples. Due to extremely low viremia, HBV genome was successfully sequenced in only two sera where subgenotype D3 was confirmed. Mutational analyses of the S gene revealed multiple missense mutations. In addition to the M133I, Y134F, and G145R mutations, already associated with diagnostic escape, we also found nine novel OBI-related S-gene mutations - S136Y, F158L, K160N, E164G, S167L, A168V, L175S, S210I and F212C. Conclusions: We detected multiple known and novel S gene mutations in 2/12 (16.6%) OBI cases, nevertheless, further studies are required to determine their role in the pathogenesis of OBI. Understanding the frequencies of clinically relevant HBV mutations may contribute to improvement of diagnostic protocols. (c) 2023 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页数:6
相关论文
共 33 条
  • [1] Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance
    Ahn, SH
    Park, YN
    Park, JY
    Chang, HY
    Lee, JM
    Shin, JE
    Han, KH
    Park, C
    Moon, YM
    Chon, CY
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 188 - 194
  • [2] Overview of hepatitis B virus mutations and their implications in the management of infection
    Caligiuri, Patrizia
    Cerruti, Rita
    Icardi, Giancarlo
    Bruzzone, Bianca
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (01) : 145 - 154
  • [3] Hepatitis B virus Blood Screening: Need for Reappraisal of Blood Safety Measures?
    Candotti, Daniel
    Laperche, Syria
    [J]. FRONTIERS IN MEDICINE, 2018, 5
  • [4] VACCINE-INDUCED ESCAPE MUTANT OF HEPATITIS-B VIRUS
    CARMAN, WF
    ZANETTI, AR
    KARAYIANNIS, P
    WATERS, J
    MANZILLO, G
    TANZI, E
    ZUCKERMAN, AJ
    THOMAS, HC
    [J]. LANCET, 1990, 336 (8711) : 325 - 329
  • [5] Hepatitis B Virus Reactivation Associated With Therapeutic Interventions
    Chang, Young
    Jeong, Soung Won
    Jang, Jae Young
    [J]. FRONTIERS IN MEDICINE, 2022, 8
  • [6] Clinical significance of hepatitis B surface antigen mutants
    Coppola, Nicola
    Onorato, Lorenzo
    Minichini, Carmine
    Di Caprio, Giovanni
    Starace, Mario
    Sagnelli, Caterina
    Sagnelli, Evangelista
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (27) : 2729 - 2739
  • [7] European Centre for Disease Prevention and Control, 2016, Systematic review on hepatitis B and C prevalence in the EU/EEA
  • [8] Grgic I, 2020, Mol Exp Biol Med, V3, P23
  • [9] GUNTHER S, 1995, J VIROL, V69, P5437
  • [10] hbv.geno2pheno, About us